Laurus Labs to acquire stake in Laurus Bio

12 Sep 2023 Evaluate

Laurus Labs has signed Share Purchase agreements with one of the Promoters and non-executive director and his family members and also with few employees/ex-employee shareholders of Laurus Bio for purchase of 37,641 equity shares through secondary purchase. With this acquisition, the shareholding of the Company in Laurus Bio will become 87.58% on fully diluted basis (including outstanding share warrants and ESOP Pool). 

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

1017.15 12.20 (1.21%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×